202 related articles for article (PubMed ID: 21813645)
1. Potentiation of Helicobacter pylori CagA protein virulence through homodimerization.
Nagase L; Murata-Kamiya N; Hatakeyama M
J Biol Chem; 2011 Sep; 286(38):33622-31. PubMed ID: 21813645
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity.
Saadat I; Higashi H; Obuse C; Umeda M; Murata-Kamiya N; Saito Y; Lu H; Ohnishi N; Azuma T; Suzuki A; Ohno S; Hatakeyama M
Nature; 2007 May; 447(7142):330-3. PubMed ID: 17507984
[TBL] [Abstract][Full Text] [Related]
3. Natural variant of the Helicobacter pylori CagA oncoprotein that lost the ability to interact with PAR1.
Hashi K; Murata-Kamiya N; Varon C; Mégraud F; Dominguez-Bello MG; Hatakeyama M
Cancer Sci; 2014 Mar; 105(3):245-51. PubMed ID: 24354359
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori stimulates epithelial cell migration via CagA-mediated perturbation of host cell signaling.
Kikuchi K; Murata-Kamiya N; Kondo S; Hatakeyama M
Microbes Infect; 2012 May; 14(5):470-6. PubMed ID: 22202178
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the origin and virulence of a Helicobacter pylori cagA-positive strain isolated from a non-human primate.
Hashi K; Imai C; Yahara K; Tahmina K; Hayashi T; Azuma T; Miyabe-Nishiwaki T; Sato H; Matsuoka M; Niimi S; Okamoto M; Hatakeyama M
Sci Rep; 2018 Oct; 8(1):15981. PubMed ID: 30374120
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional diversity in the PAR1b/MARK2-binding region of Helicobacter pylori CagA.
Lu HS; Saito Y; Umeda M; Murata-Kamiya N; Zhang HM; Higashi H; Hatakeyama M
Cancer Sci; 2008 Oct; 99(10):2004-11. PubMed ID: 19016760
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori CagA oncoprotein interacts with SHIP2 to increase its delivery into gastric epithelial cells.
Fujii Y; Murata-Kamiya N; Hatakeyama M
Cancer Sci; 2020 May; 111(5):1596-1606. PubMed ID: 32198795
[TBL] [Abstract][Full Text] [Related]
8. EPIYA motif is a membrane-targeting signal of Helicobacter pylori virulence factor CagA in mammalian cells.
Higashi H; Yokoyama K; Fujii Y; Ren S; Yuasa H; Saadat I; Murata-Kamiya N; Azuma T; Hatakeyama M
J Biol Chem; 2005 Jun; 280(24):23130-7. PubMed ID: 15831497
[TBL] [Abstract][Full Text] [Related]
9. Role of partitioning-defective 1/microtubule affinity-regulating kinases in the morphogenetic activity of Helicobacter pylori CagA.
Lu H; Murata-Kamiya N; Saito Y; Hatakeyama M
J Biol Chem; 2009 Aug; 284(34):23024-36. PubMed ID: 19553659
[TBL] [Abstract][Full Text] [Related]
10. Focal adhesion kinase is a substrate and downstream effector of SHP-2 complexed with Helicobacter pylori CagA.
Tsutsumi R; Takahashi A; Azuma T; Higashi H; Hatakeyama M
Mol Cell Biol; 2006 Jan; 26(1):261-76. PubMed ID: 16354697
[TBL] [Abstract][Full Text] [Related]
11. Dramatic increase in SHP2 binding activity of Helicobacter pylori Western CagA by EPIYA-C duplication: its implications in gastric carcinogenesis.
Nagase L; Hayashi T; Senda T; Hatakeyama M
Sci Rep; 2015 Oct; 5():15749. PubMed ID: 26507409
[TBL] [Abstract][Full Text] [Related]
12. Structural basis and functional consequence of Helicobacter pylori CagA multimerization in cells.
Ren S; Higashi H; Lu H; Azuma T; Hatakeyama M
J Biol Chem; 2006 Oct; 281(43):32344-52. PubMed ID: 16954210
[TBL] [Abstract][Full Text] [Related]
13. Differential Mechanisms for SHP2 Binding and Activation Are Exploited by Geographically Distinct Helicobacter pylori CagA Oncoproteins.
Hayashi T; Senda M; Suzuki N; Nishikawa H; Ben C; Tang C; Nagase L; Inoue K; Senda T; Hatakeyama M
Cell Rep; 2017 Sep; 20(12):2876-2890. PubMed ID: 28930683
[TBL] [Abstract][Full Text] [Related]
14. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites.
Higashi H; Tsutsumi R; Fujita A; Yamazaki S; Asaka M; Azuma T; Hatakeyama M
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14428-33. PubMed ID: 12391297
[TBL] [Abstract][Full Text] [Related]
15. Malignant Helicobacter pylori-Associated Diseases: Gastric Cancer and MALT Lymphoma.
Hatakeyama M
Adv Exp Med Biol; 2019; 1149():135-149. PubMed ID: 31016622
[TBL] [Abstract][Full Text] [Related]
16. Host SHP1 phosphatase antagonizes Helicobacter pylori CagA and can be downregulated by Epstein-Barr virus.
Saju P; Murata-Kamiya N; Hayashi T; Senda Y; Nagase L; Noda S; Matsusaka K; Funata S; Kunita A; Urabe M; Seto Y; Fukayama M; Kaneda A; Hatakeyama M
Nat Microbiol; 2016 Mar; 1():16026. PubMed ID: 27572445
[TBL] [Abstract][Full Text] [Related]
17. Deregulation of SHP-2 tyrosine phosphatase by the Helicobacter pylori virulence factor CagA.
Hatakeyama M
Keio J Med; 2002 Dec; 51 Suppl 2():26-32. PubMed ID: 12528933
[TBL] [Abstract][Full Text] [Related]
18. Systematic analysis of phosphotyrosine antibodies recognizing single phosphorylated EPIYA-motifs in CagA of East Asian-type Helicobacter pylori strains.
Lind J; Backert S; Hoffmann R; Eichler J; Yamaoka Y; Perez-Perez GI; Torres J; Sticht H; Tegtmeyer N
BMC Microbiol; 2016 Sep; 16(1):201. PubMed ID: 27590005
[TBL] [Abstract][Full Text] [Related]
19. Sequence Polymorphism and Intrinsic Structural Disorder as Related to Pathobiological Performance of the Helicobacter pylori CagA Oncoprotein.
Nishikawa H; Hatakeyama M
Toxins (Basel); 2017 Apr; 9(4):. PubMed ID: 28406453
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori CagA elicits BRCAness to induce genome instability that may underlie bacterial gastric carcinogenesis.
Imai S; Ooki T; Murata-Kamiya N; Komura D; Tahmina K; Wu W; Takahashi-Kanemitsu A; Knight CT; Kunita A; Suzuki N; Del Valle AA; Tsuboi M; Hata M; Hayakawa Y; Ohnishi N; Ueda K; Fukayama M; Ushiku T; Ishikawa S; Hatakeyama M
Cell Host Microbe; 2021 Jun; 29(6):941-958.e10. PubMed ID: 33989515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
